Selected research
Market Outlook & Growth Opportunities
Global Pharmaceutical Equipment Testing Market Outlook and Growth Opportunities 2026
Market perspective
The global Pharmaceutical Equipment Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Pharmaceutical Equipment Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharmaceutical Equipment Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Equipment Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Pharmaceutical Equipment Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Pharmaceutical Equipment Testing market include Thermo Fisher Scientific Inc, Charles River Laboratories, AMETEK Sensors, Test & Calibration (STC), Pace Analytical Services, LLC, Edwards Analyticals, Envigo, Fison Instruments Ltd, DJA Pharma and Copley, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Pharmaceutical Equipment Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharmaceutical Equipment Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharmaceutical Equipment Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical Equipment Testing market.
Pharmaceutical Equipment Testing Segment by Company
Thermo Fisher Scientific Inc
Charles River Laboratories
AMETEK Sensors, Test & Calibration (STC)
Pace Analytical Services, LLC
Edwards Analyticals
Envigo
Fison Instruments Ltd
DJA Pharma
Copley
SGS Société Générale de Surveillance SA
Pharma Test
ADPEN Laboratories Inc
Full Spectrum Group
Intertek Group plc
Element
Eurofins Scientific
RD Laboratories Inc
Dynalabs
West Pharmaceutical Services, Inc
Boston Analytical
Microbac Laboratories Inc
TASI Group
ARL Bio Pharma, Inc
Panomex Inc
Scilogex
Pharmaceutical Equipment Testing Segment by Type
Container Testing
Life Testing
Functional Testing
Stability Testing
Raw Material Testing
Microbial Testing
Others
Pharmaceutical Equipment Testing Segment by Application
Pharmaceutical Companies
Government Organization
Research Institutes
Testing Laboratories
Others
Pharmaceutical Equipment Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Pharmaceutical Equipment Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Pharmaceutical Equipment Testing key companies, revenue, market share, and recent developments.
3. To split the Pharmaceutical Equipment Testing breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Pharmaceutical Equipment Testing market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pharmaceutical Equipment Testing significant trends, drivers, influence factors in global and regions.
6. To analyze Pharmaceutical Equipment Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Equipment Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Equipment Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Equipment Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Equipment Testing industry.
Chapter 3: Detailed analysis of Pharmaceutical Equipment Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Pharmaceutical Equipment Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Pharmaceutical Equipment Testing in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Container Testing
- Life Testing
- Functional Testing
- Stability Testing
- Raw Material Testing
- Microbial Testing
- Others
Applications
- Pharmaceutical Companies
- Government Organization
- Research Institutes
- Testing Laboratories
- Others
Companies covered
- Thermo Fisher Scientific Inc
- Charles River Laboratories
- AMETEK Sensors, Test & Calibration (STC)
- Pace Analytical Services, LLC
- Edwards Analyticals
- Envigo
- Fison Instruments Ltd
- DJA Pharma
- Copley
- SGS Société Générale de Surveillance SA
- Pharma Test
- ADPEN Laboratories Inc
- Full Spectrum Group
- Intertek Group plc
- Element
- Eurofins Scientific
- RD Laboratories Inc
- Dynalabs
- West Pharmaceutical Services, Inc
- Boston Analytical
- Microbac Laboratories Inc
- TASI Group
- ARL Bio Pharma, Inc
- Panomex Inc
- Scilogex
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pharmaceutical Equipment Testing Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pharmaceutical Equipment Testing Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pharmaceutical Equipment Testing Market Dynamics
- 2.1 Pharmaceutical Equipment Testing Industry Trends
- 2.2 Pharmaceutical Equipment Testing Industry Drivers
- 2.3 Pharmaceutical Equipment Testing Industry Opportunities and Challenges
- 2.4 Pharmaceutical Equipment Testing Industry Restraints
3 Pharmaceutical Equipment Testing Market by Company
- 3.1 Global Pharmaceutical Equipment Testing Company Revenue Ranking in 2025
- 3.2 Global Pharmaceutical Equipment Testing Revenue by Company (2021-2026)
- 3.3 Global Pharmaceutical Equipment Testing Company Ranking (2024-2026)
- 3.4 Global Pharmaceutical Equipment Testing Company Manufacturing Base and Headquarters
- 3.5 Global Pharmaceutical Equipment Testing Company Product Type and Application
- 3.6 Global Pharmaceutical Equipment Testing Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Pharmaceutical Equipment Testing Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Pharmaceutical Equipment Testing Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical Equipment Testing Market by Type
- 4.1 Pharmaceutical Equipment Testing Type Introduction
- 4.1.1 Container Testing
- 4.1.2 Life Testing
- 4.1.3 Functional Testing
- 4.1.4 Stability Testing
- 4.1.5 Raw Material Testing
- 4.1.6 Microbial Testing
- 4.1.7 Others
- 4.2 Global Pharmaceutical Equipment Testing Sales Value by Type
- 4.2.1 Global Pharmaceutical Equipment Testing Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pharmaceutical Equipment Testing Sales Value by Type (2021-2032)
- 4.2.3 Global Pharmaceutical Equipment Testing Sales Value Share by Type (2021-2032)
5 Pharmaceutical Equipment Testing Market by Application
- 5.1 Pharmaceutical Equipment Testing Application Introduction
- 5.1.1 Pharmaceutical Companies
- 5.1.2 Government Organization
- 5.1.3 Research Institutes
- 5.1.4 Testing Laboratories
- 5.1.5 Others
- 5.2 Global Pharmaceutical Equipment Testing Sales Value by Application
- 5.2.1 Global Pharmaceutical Equipment Testing Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pharmaceutical Equipment Testing Sales Value by Application (2021-2032)
- 5.2.3 Global Pharmaceutical Equipment Testing Sales Value Share by Application (2021-2032)
6 Pharmaceutical Equipment Testing Regional Value Analysis
- 6.1 Global Pharmaceutical Equipment Testing Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pharmaceutical Equipment Testing Sales Value by Region (2021-2032)
- 6.2.1 Global Pharmaceutical Equipment Testing Sales Value by Region: 2021-2026
- 6.2.2 Global Pharmaceutical Equipment Testing Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pharmaceutical Equipment Testing Sales Value (2021-2032)
- 6.3.2 North America Pharmaceutical Equipment Testing Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Pharmaceutical Equipment Testing Sales Value (2021-2032)
- 6.4.2 Europe Pharmaceutical Equipment Testing Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Pharmaceutical Equipment Testing Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Pharmaceutical Equipment Testing Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Pharmaceutical Equipment Testing Sales Value (2021-2032)
- 6.6.2 South America Pharmaceutical Equipment Testing Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Pharmaceutical Equipment Testing Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Pharmaceutical Equipment Testing Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Equipment Testing Country-level Value Analysis
- 7.1 Global Pharmaceutical Equipment Testing Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Pharmaceutical Equipment Testing Sales Value by Country (2021-2032)
- 7.2.1 Global Pharmaceutical Equipment Testing Sales Value by Country (2021-2026)
- 7.2.2 Global Pharmaceutical Equipment Testing Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.7.2 France Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.14.2 China Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.17.2 India Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Pharmaceutical Equipment Testing Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Pharmaceutical Equipment Testing Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Pharmaceutical Equipment Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Thermo Fisher Scientific Inc
- 8.1.1 Thermo Fisher Scientific Inc Company Information
- 8.1.2 Thermo Fisher Scientific Inc Business Overview
- 8.1.3 Thermo Fisher Scientific Inc Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.1.4 Thermo Fisher Scientific Inc Pharmaceutical Equipment Testing Product Portfolio
- 8.1.5 Thermo Fisher Scientific Inc Recent Developments
- 8.2 Charles River Laboratories
- 8.2.1 Charles River Laboratories Company Information
- 8.2.2 Charles River Laboratories Business Overview
- 8.2.3 Charles River Laboratories Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.2.4 Charles River Laboratories Pharmaceutical Equipment Testing Product Portfolio
- 8.2.5 Charles River Laboratories Recent Developments
- 8.3 AMETEK Sensors, Test & Calibration (STC)
- 8.3.1 AMETEK Sensors, Test & Calibration (STC) Company Information
- 8.3.2 AMETEK Sensors, Test & Calibration (STC) Business Overview
- 8.3.3 AMETEK Sensors, Test & Calibration (STC) Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.3.4 AMETEK Sensors, Test & Calibration (STC) Pharmaceutical Equipment Testing Product Portfolio
- 8.3.5 AMETEK Sensors, Test & Calibration (STC) Recent Developments
- 8.4 Pace Analytical Services, LLC
- 8.4.1 Pace Analytical Services, LLC Company Information
- 8.4.2 Pace Analytical Services, LLC Business Overview
- 8.4.3 Pace Analytical Services, LLC Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.4.4 Pace Analytical Services, LLC Pharmaceutical Equipment Testing Product Portfolio
- 8.4.5 Pace Analytical Services, LLC Recent Developments
- 8.5 Edwards Analyticals
- 8.5.1 Edwards Analyticals Company Information
- 8.5.2 Edwards Analyticals Business Overview
- 8.5.3 Edwards Analyticals Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.5.4 Edwards Analyticals Pharmaceutical Equipment Testing Product Portfolio
- 8.5.5 Edwards Analyticals Recent Developments
- 8.6 Envigo
- 8.6.1 Envigo Company Information
- 8.6.2 Envigo Business Overview
- 8.6.3 Envigo Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.6.4 Envigo Pharmaceutical Equipment Testing Product Portfolio
- 8.6.5 Envigo Recent Developments
- 8.7 Fison Instruments Ltd
- 8.7.1 Fison Instruments Ltd Company Information
- 8.7.2 Fison Instruments Ltd Business Overview
- 8.7.3 Fison Instruments Ltd Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.7.4 Fison Instruments Ltd Pharmaceutical Equipment Testing Product Portfolio
- 8.7.5 Fison Instruments Ltd Recent Developments
- 8.8 DJA Pharma
- 8.8.1 DJA Pharma Company Information
- 8.8.2 DJA Pharma Business Overview
- 8.8.3 DJA Pharma Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.8.4 DJA Pharma Pharmaceutical Equipment Testing Product Portfolio
- 8.8.5 DJA Pharma Recent Developments
- 8.9 Copley
- 8.9.1 Copley Company Information
- 8.9.2 Copley Business Overview
- 8.9.3 Copley Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.9.4 Copley Pharmaceutical Equipment Testing Product Portfolio
- 8.9.5 Copley Recent Developments
- 8.10 SGS Société Générale de Surveillance SA
- 8.10.1 SGS Société Générale de Surveillance SA Company Information
- 8.10.2 SGS Société Générale de Surveillance SA Business Overview
- 8.10.3 SGS Société Générale de Surveillance SA Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.10.4 SGS Société Générale de Surveillance SA Pharmaceutical Equipment Testing Product Portfolio
- 8.10.5 SGS Société Générale de Surveillance SA Recent Developments
- 8.11 Pharma Test
- 8.11.1 Pharma Test Company Information
- 8.11.2 Pharma Test Business Overview
- 8.11.3 Pharma Test Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.11.4 Pharma Test Pharmaceutical Equipment Testing Product Portfolio
- 8.11.5 Pharma Test Recent Developments
- 8.12 ADPEN Laboratories Inc
- 8.12.1 ADPEN Laboratories Inc Company Information
- 8.12.2 ADPEN Laboratories Inc Business Overview
- 8.12.3 ADPEN Laboratories Inc Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.12.4 ADPEN Laboratories Inc Pharmaceutical Equipment Testing Product Portfolio
- 8.12.5 ADPEN Laboratories Inc Recent Developments
- 8.13 Full Spectrum Group
- 8.13.1 Full Spectrum Group Company Information
- 8.13.2 Full Spectrum Group Business Overview
- 8.13.3 Full Spectrum Group Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.13.4 Full Spectrum Group Pharmaceutical Equipment Testing Product Portfolio
- 8.13.5 Full Spectrum Group Recent Developments
- 8.14 Intertek Group plc
- 8.14.1 Intertek Group plc Company Information
- 8.14.2 Intertek Group plc Business Overview
- 8.14.3 Intertek Group plc Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.14.4 Intertek Group plc Pharmaceutical Equipment Testing Product Portfolio
- 8.14.5 Intertek Group plc Recent Developments
- 8.15 Element
- 8.15.1 Element Company Information
- 8.15.2 Element Business Overview
- 8.15.3 Element Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.15.4 Element Pharmaceutical Equipment Testing Product Portfolio
- 8.15.5 Element Recent Developments
- 8.16 Eurofins Scientific
- 8.16.1 Eurofins Scientific Company Information
- 8.16.2 Eurofins Scientific Business Overview
- 8.16.3 Eurofins Scientific Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.16.4 Eurofins Scientific Pharmaceutical Equipment Testing Product Portfolio
- 8.16.5 Eurofins Scientific Recent Developments
- 8.17 RD Laboratories Inc
- 8.17.1 RD Laboratories Inc Company Information
- 8.17.2 RD Laboratories Inc Business Overview
- 8.17.3 RD Laboratories Inc Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.17.4 RD Laboratories Inc Pharmaceutical Equipment Testing Product Portfolio
- 8.17.5 RD Laboratories Inc Recent Developments
- 8.18 Dynalabs
- 8.18.1 Dynalabs Company Information
- 8.18.2 Dynalabs Business Overview
- 8.18.3 Dynalabs Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.18.4 Dynalabs Pharmaceutical Equipment Testing Product Portfolio
- 8.18.5 Dynalabs Recent Developments
- 8.19 West Pharmaceutical Services, Inc
- 8.19.1 West Pharmaceutical Services, Inc Company Information
- 8.19.2 West Pharmaceutical Services, Inc Business Overview
- 8.19.3 West Pharmaceutical Services, Inc Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.19.4 West Pharmaceutical Services, Inc Pharmaceutical Equipment Testing Product Portfolio
- 8.19.5 West Pharmaceutical Services, Inc Recent Developments
- 8.20 Boston Analytical
- 8.20.1 Boston Analytical Company Information
- 8.20.2 Boston Analytical Business Overview
- 8.20.3 Boston Analytical Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.20.4 Boston Analytical Pharmaceutical Equipment Testing Product Portfolio
- 8.20.5 Boston Analytical Recent Developments
- 8.21 Microbac Laboratories Inc
- 8.21.1 Microbac Laboratories Inc Company Information
- 8.21.2 Microbac Laboratories Inc Business Overview
- 8.21.3 Microbac Laboratories Inc Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.21.4 Microbac Laboratories Inc Pharmaceutical Equipment Testing Product Portfolio
- 8.21.5 Microbac Laboratories Inc Recent Developments
- 8.22 TASI Group
- 8.22.1 TASI Group Company Information
- 8.22.2 TASI Group Business Overview
- 8.22.3 TASI Group Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.22.4 TASI Group Pharmaceutical Equipment Testing Product Portfolio
- 8.22.5 TASI Group Recent Developments
- 8.23 ARL Bio Pharma, Inc
- 8.23.1 ARL Bio Pharma, Inc Company Information
- 8.23.2 ARL Bio Pharma, Inc Business Overview
- 8.23.3 ARL Bio Pharma, Inc Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.23.4 ARL Bio Pharma, Inc Pharmaceutical Equipment Testing Product Portfolio
- 8.23.5 ARL Bio Pharma, Inc Recent Developments
- 8.24 Panomex Inc
- 8.24.1 Panomex Inc Company Information
- 8.24.2 Panomex Inc Business Overview
- 8.24.3 Panomex Inc Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.24.4 Panomex Inc Pharmaceutical Equipment Testing Product Portfolio
- 8.24.5 Panomex Inc Recent Developments
- 8.25 Scilogex
- 8.25.1 Scilogex Company Information
- 8.25.2 Scilogex Business Overview
- 8.25.3 Scilogex Pharmaceutical Equipment Testing Revenue and Gross Margin (2021-2026)
- 8.25.4 Scilogex Pharmaceutical Equipment Testing Product Portfolio
- 8.25.5 Scilogex Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst